ey0016.7-15 | Treatment | ESPEYB16
T Varimo
, H Huopio
, L Kariola
, S Tenhola
, R Voutilainen
, J Toppari
, S Toiviainen-Salo
, E Hamalainen
, MA Pulkkinen
, M Laaperi
, A Tarkkanen
, K Vaaralahti
, PJ Miettinen
, M Hero
, T Raivio
To read the full abstract: Lancet Child Adolesc Health. 2019 Feb;3(2):109120This randomised, controlled, open-label trial at four paediatric centres in Finland evaluates aromatase inhibition with letrozole to induce puberty in boys with constitutional delay of growth and puberty.Treatment of delayed puberty aims to promote pubertal development ...